47 results on '"Bogorad, Roman L"'
Search Results
2. RNAi-nanoparticulate manipulation of gene expression as a new functional genomics tool in the liver
3. Lipopeptide nanoparticles for potent and selective siRNA delivery in rodents and nonhuman primates
4. Treatment of erythropoietin deficiency in mice with systemically administered siRNA
5. Local prolactin is a target to prevent expansion of basal/stem cells in prostate tumors
6. Identification of a Gain-of-Function Mutation of the Prolactin Receptor in Women with Benign Breast Tumors
7. Control of hepatocyte proliferation and survival by Fgf receptors is essential for liver regeneration in mice
8. Rab5 is necessary for the biogenesis of the endolysosomal system in vivo
9. Integrative genomics identifies MCU as an essential component of the mitochondrial calcium uniporter
10. Liver-Specific siRNA-Mediated Stat3 or C3 Knockdown Improves the Outcome of Experimental Autoimmune Myocarditis
11. Identification of Gain-of-Function Variants of the Human Prolactin Receptor
12. Prolactin regulation of the prostate gland: a female player in a male game
13. Liquid-crystal organization of liver tissue
14. Author response: Liquid-crystal organization of liver tissue
15. Large-Scale Quantitative Proteomics Identifies the Ubiquitin Ligase Nedd4-1 as an Essential Regulator of Liver Regeneration
16. Liquid-crystal organization of liver tissue
17. Partial DNA-guided Cas9 enables genome editing with reduced off-target activity
18. Identification of cell cycle-targeting microRNAs through genome-wide screens
19. Structure-guided chemical modification of guide RNA enables potent non-viral in vivo genome editing
20. Large-Scale Quantitative Proteomics Identifies the Ubiquitin Ligase Nedd4-1 as an Essential Regulator of Liver Regeneration
21. Control of liver size by RNAi-mediated multiplex knockdown and its application for discovery of regulatory mechanisms
22. Cell-Cycle-Targeting MicroRNAs as Therapeutic Tools against Refractory Cancers
23. Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo
24. Regulation of Liver Metabolism by the Endosomal GTPase Rab5
25. Residue 146 regulates prolactin receptor folding, basal activity and ligand-responsiveness: Potential implications in breast tumorigenesis
26. Control of hepatocyte proliferation and survival by Fgf receptors is essential for liver regeneration in mice
27. Loss of α-catenin elicits a cholestatic response and impairs liver regeneration
28. Ionizable Amphiphilic Dendrimer-Based Nanomaterials with Alkyl-Chain-Substituted Amines for Tunable siRNA Delivery to the Liver Endothelium In Vivo
29. Erratum: Corrigendum: Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype
30. The Roles of Individual Mammalian Argonautes in RNA Interference In Vivo
31. Knockdown and knockout of β1-integrin in hepatocytes impairs liver regeneration through inhibition of growth factor signalling
32. Nanoparticle-formulated siRNA targeting integrins inhibits hepatocellular carcinoma progression in mice
33. In vivo endothelial siRNA delivery using polymeric nanoparticles with low molecular weight
34. Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype
35. MICU2, a Paralog of MICU1, Resides within the Mitochondrial Uniporter Complex to Regulate Calcium Handling
36. Systemic RNAi-mediated Gene Silencing in Nonhuman Primate and Rodent Myeloid Cells
37. Prolactin Levels and the Risk of Future Coronary Artery Disease in Apparently Healthy Men and Women
38. JAK-STAT pathway in carcinogenesis: Is it relevant to cholangiocarcinoma progression?
39. Loss of α-catenin elicits a cholestatic response and impairs liver regeneration.
40. Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo
41. The Roles of Individual Mammalian Argonautes in RNA Interference In Vivo.
42. Lipopeptide nanoparticles for potent and selective siRNA delivery in rodents and nonhuman primates.
43. Corrigendum: Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype.
44. The Roles of Individual Mammalian Argonautes in RNA Interference In Vivo.
45. In vivo endothelial siRNA delivery using polymeric nanoparticles with low molecular weight
46. Nanoparticle-formulated siRNA targeting integrins inhibits hepatocellular carcinoma progression in mice
47. Identification of gain-of-function variants of the human prolactin receptor.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.